• Genitourinary
Name No. Patient Profile Purpose
E7080-G000-307 16-69

Advanced/metastatic renal cell carcinoma (kidney cancer).

The purpose of this trial is to assess the safety and efficacy of the drug lenvatinib in combination with everolimus or pembrolizumab versus sunitinib alone in first-line treatment of participants with advanced renal cell carcinoma.


  • Genitourinary
Name No. Patient Profile Purpose
CA209-274 16-70

Cancer originating in the bladder, ureter or renal pelvis

The purpose of this trial is to determine if the drug nivolumab versus placebo prevents cancer recurrence in participants with bladder or upper urinary tract cancer, following surgery to remove the cancer.


  • Genitourinary
Name No. Patient Profile Purpose
WO39210/IMmotion010 16-63

Renal cell carcinoma at high risk of developing metastasis following nephrectomy (removal of the kidney).

The purpose of the trial is to determine if the new drug atezolizumab is safe and effective.


  • Genitourinary
Name No. Patient Profile Purpose
IPCOR 16-07

Prostate cancer

The main objective is to collect detailed clinical and quality of life data on Irish men’s prostate cancer journey.


  • Genitourinary
Name No. Patient Profile Purpose
CARD 15-19

Advanced prostate cancer

The purpose of the trial is to compare the effectiveness of two different treatments.


  • Genitourinary
Name No. Patient Profile Purpose
iProspect 14-04

Advanced prostate cancer.

The purpose of the trial is to investigate new clinical tests that could predict what treatments work best for certain patients with advanced prostate cancer.


  • Genitourinary
Name No. Patient Profile Purpose
Neo-adjuvant abiraterone prostate study 13-23

Prostate cancer.

The purpose of this trial is to focus on the potential role of the drug abiraterone acetate.


  • Genitourinary
Name No. Patient Profile Purpose
PEACE-1 13-09

Metastatic hormone-sensitive prostate cancer

The purpose of this trial is to study the effect of the standard treatment by Androgen deprivation Therapy (ADT) (+/- Docetaxel), with or without radiotherapy, with or without abiraterone acetate and prednisone in patient with metastatic hormone-naïve prostate cancer.


  • Genitourinary
Name No. Patient Profile Purpose
Tiger 11-34

Testicular tumours that have returned.

The purpose of this trial is to compare two different doses of chemotherapy.